Skip Navigation Bar
Lectures on Tuberculosis, Fort Bayard 1910-1914
full text File Size: 17 K bytes | Add this to my bookbag

Contents List

Box | Folder Title
 
Series 1: Personal and Biographical, 1933-2008 [series]:
1 1
Biographical sketches, 1993-1998
1 2
Scrapbook, 1950-1973
1 3-6
CVs and bibliography, 1987-2004
1 7
High school essays, 1940-1941
1 8
University of Chicago - correspondence, 1942-1949
1 9
University of Chicago Medical and Biological Sciences Alumni Association - reunion class of 1947 - dinner menu and yearbook, 1997
1 10-12
University of Chicago - course notes, lab procedures, dietary formulations, 1948-1950
69 1
Sydenham Hospital patient records, 1948 [RESTRICTED PHI POLICY]
1 13
Medical license, 1976-1994
1 14
Army discharge, 1946
1 15-22
U.S. Army service in Korea - correspondence, orders, data, 1949-1955
69 3
U.S. Army - Korea - Q fever and scrub typhus, 1953 [RESTRICTED PHI POLICY]
1 23-26
University of Cincinnati College of Medicine fellow - correspondence, reports, 1950-1952
1 27
Children's Hospital Research Foundation - correspondence, 1955-1956
69 4
University of Cincinnati College of Medicine, 1955 [RESTRICTED PHI POLICY]
1 28-30
Johns Hopkins - correspondence, laboratory manual, notes, 1956-1957
1 31-34
PHS Commissioned Officer - orders, correspondence, identification, retirement, 1957-1988
1 35-37
National Institute of Allergies and Infectious Diseases Oral History Interview - conducted by Peggy Dillon, 2001-2003
1 38
Retirement guestbook, c.2008
 
Family Correspondence, 1933-1995 [subseries]:
1 39
From Robert to his family, 1933
1 40
From Robert to Beth Chanock, 1948-1955
1 41
Notes, c.1950s
1 42
Well wishes on pericarditis, 1967
2 1
Family and friends, 1968-1995
2 2
Congratulations on birth of grandson, 1983
2 3
Chanock, Foster Osgood, 1975-1980
2 4
Chanock, Frances E., 1995
2 5
Chanock, Stephen J., 1971-1989
 
Awards and Honors, 1945-2008 [subseries]:
2 6
Various certificates, 1945-2008
2 7
E. Mead Johnson Award for Research in Pediatrics - congratulations and correspondence, 27 October 1964
2 8
Kimble Methodology Award - letters of congratulations and correspondence, 31 October 1966
2 9
Infectious Diseases Society of America Squibb Award - congratulations, correspondence, and acceptance speech, 25 October 1969
2 10
DHEW Distinguished Service Medal - correspondence, photographs, and ceremony program, 15 April 1971
2 11
Gorgas Medal - announcement and clipping, 11 December 1972
2 12
Election to National Academy of Sciences - letters of congratulations, 1973
2 13
Howard Taylor Ricketts Award - announcement, congratulations, event program, lecture transcript, 14 May 1973
2 14
Award for Distinguished Achievement - announcement, 1976
2 15
University of Chicago - honorary doctorate - announcement, photographs, and convocation program, 14 November 1977
2 16-17
Robert Koch Stiftung Award - correspondence, letters of congratulations, ceremony program, photographs, lecture transcript, 7 December 1981
2 18-23
ICN International Prize in Virology - announcement, correspondence, letters of congratulations, ceremony program, photographs, 7 February 1991
2 24
Presidential Meritorious Executive Rank Award, 1993
2 25-26
Bristol-Myers Squibb Award for Distinguished Achievement in Infectious Disease Research - announcement, letters of congratulations, ceremony program, and clippings, 7 December 1993
2 27
Albert B. Sabin Gold Medal Award - letters of congratulations, ceremony program, lecture transcript, and clippings, 14 September 1995
2 28
American College of Physicians Award for Outstanding Work in Science as Related to Medicine - correspondence, May 2008
 
Photographs, c.1950s-2005 [subseries]:
2 29
Aboard the 'Independence', c.1950s
2 30
Dr. Chanock's friends and colleagues, c.1960s-2000s
2 31-33
Dr. Chanock - with family, in groups, in PHS uniform, at conferences, in laboratory, 1988-1998, undated
2 34
A celebration of the career of Dr. Robert M. Chanock, Laboratory of Infectious Diseases, NIAID, NIH, 21 October 2005
 
Clippings, 1954-2008 [subseries]:
2 35-37
General, 1958-2008
3 1
Obituaries of colleagues, 1995-1998
3 2
re Influenza, 1947-1998
3 3
Virus discoveries, 1954-1980
Born Digital
Archive-It web archive, top results for "Robert Chanock" Google search conducted by HMD staff, 2018 [view online]
 
Series 2: NIH-NIAID-Laboratory of Infectious Diseases (LID), 1955-2008 [series]:
3 4-14
NIAID Annual Reports, 1967-1972
4 1-14
NIAID Annual Reports (cont'd), 1973-1980
5 1-5
NIAID Annual Reports (cont'd), 1980-1983
5 6-13
LID Board of Scientific Counselors Review, 1978, 1981, 1984, 1987, 1992, 1996
6 1-11
LID Board of Scientific Counselors Review (cont'd), 1996, 2000, 2003, 2004
6 12-23
LID Annual Reports [3.5 computer disks], 1966-1970; 1972-1973, 1976, 1982, 1984, 1985, 1987
7 1-14
LID Annual Reports (cont'd), 1987-1996
8 1-2
LID Annual Reports (cont'd), 1996-1997
8 3-35
Calendar - Dr. Chanock's, 1971-2006
 
Correspondence, 1955-2008 [subseries]:
8 36-50
Alphabetical by correspondent - A-H, 1957-1968
9 1-19
Alphabetical by correspondent - H-W, 1957-1968
9 20-25
Alphabetical by correspondent - A-L, 1969-1975
10 1-6
Alphabetical by correspondent - M-Z, 1969-1975
10 7-24
Alphabetical by correspondent - A-T, 1975-1996
10 25-27
Alphabetical by correspondent - A-Z, 1978-1979
10 28
Becker, Walter B., 1963-1971
10 29
Brown, Fred, 1989-1992
10 30
Children's Hospital, Philadelphia - Dr. Lief, 1964-1966
10 31
Croup agent, 1955-1958
10 32
Fenner, Frank, 1978-1997
10 33
Roizman, Bernard, 1974-1988
10 34
Siim, J. Christian, 1979-1991
10 35
Stuart-Harris, Charles, 1977-1983
10 36
Syrucek, Lubomir, 1965-1972
10 37
Walter Reed Army Medical Center, 1962-1969
10 38
Wyeth Laboratories, 1964-1969
10 39-41
Chronological Files, 1968, 1971-1972
11 1-21
Chronological Files, 1973-1981, 1984-1986, 1989-1993, 1995
11 22-44
Chronological miscellaneous correspondence, undated, 1957-1980
12 1-28
Chronological miscellaneous correspondence (cont'd), 1981-2008
 
Correspondence of Harry Greenberg and Anthony Kalica, 1976-1983 [subseries]:
12 29
Greenberg, Harry correspondence - A-Z by correspondent name, 1976-1983
12 30
Kalica, Anthony correspondence - A-Z by correspondent name, 1976-1982
13 1
Kalica, Anthony correspondence - A-Z by correspondent name (cont'd), 1976-1982
 
Subjects, 1955-2007 [subseries]:
13 2-5
1918 Flu 2005 Avian Flu, 2002-2006
13 6
4 New Breast Cancer Genes / DNA Variations for 7 Diseases, 2007
13 7-8
Acambis, 1999-2007
13 9
Adenovirus and AAV, 1964-2001
13 10
Adjuvants for influenza virus vaccines, including use for H5N1 if needed, 2006
13 11
Agracetus [photocopy of 1947 article], undated
13 12-13
Albert B. Sabin Vaccine Foundation, Inc., 1991-1994
13 14-15
Anthrax, 1999-2004
13 16
Anthrax incidents, hoaxes and threats, 1999
13 17
Armed Forces Epidemiological Board (AFEB) - 50th year anniversary, 28 June 1990
13 18-19
AFEB Commission on Acute Respiratory Diseases - annual reports, 1969, 2001
13 20
AFEB Commission on Influenza - annual report, 1971
13 21
Australian National University - annual reports, 1961-1967
13 22-23
Avian flu, 2002-2007
13 24
Biodefense NIAID, 2002
13 25
Bioshield 5105, 2005
13 26
Bioterrorist activities - Peter Jahrling, Ph.D. [35mm slides], 29 January 1999
13 27
Biowarfare, 1988-1994
13 28
Byrne, Robert J., D.V.M. - Deputy Director, Experimental Applications Branch, NIAID, 1979-1980
13 29
Chiefs of NIAID [photographs], 2001
14 1
Choppin, Purnell, c.1985
14 2
Cold Spring Harbor correspondence, 1986
14 3
Conflict of interest issues, 2005
14 4
Consultancies - Molecular Vaccines, Inc., and Medimmune, 1988-2002
14 5
Dangers of mutants, 1977
14 6
Dengue - Jo Blaney, 28 November 2007
14 7
Dengue vaccine, c.1989
14 8
Inter-Divisional Vaccine Working Group, 17 September 1993
14 9
Edelman memos and correspondence, 1976-1988
14 10
Ethics - L.A. Times, September-October 2004
14 11
Executive office NIAID, 1985-1988
14 12
Fauci, Dr. Anthony - Director NIAID, 1985-1987
14 13-15
Food and Drug Administration (FDA) - Panel on Review of Viral Vaccines and Rickettsial Vaccines, 1975
14 16
Freezer repository - inventory contents, 1992
14 17
Gallin, Dr. John - Director, Intramural Research Program, NIAID, 1985-1988
 
Goldberg II [subseries]:

Articles sent to Dr. Chanock by journalist Billie Goldberg organized thematically.

14 18
Antivirals, 2005
14 19
Cancer, 2005
14 20
Dengue, 2005
14 21
DNA vaccines, 2005
14 22
Ebola and Marburg vaccines, 2005
14 23
HIV SIV, 2005
14 24
Human melanoma virus, 2005
14 25
Immunology, 2005
14 26
Nobel, 2005
14 27
RNAi, 2005
14 28
Shingles, 2005
14 29
Aviflu, 2006
14 30
Biodefense tick borne encephalitis virus, 2006
14 31
HIV vaccine, 2006
14 32
Important role of inflammation in cardiovascular disease, 2006
14 33
Kaposi sarcoma virus receptor, 2006
14 34
Old viruses resurrected inhuman DNA, 2006
14 35
Osteoporosis protein diabetes genes, 2006
14 36
Polio-Weimmer, 2006
14 37
Prostate cancer Rx therapy, 2006
14 38
RNAi clinical, 2006
14 39
Max Theiler 1951, 2006
14 40
Vertex HCV, 2006
14 41
Vioxx Merck, 2006
14 42
West Nile transplant patients, 2006
14 43-44
Hartley, Janet, 1981-1994
14 45
House hearings on influenza vaccine, August 1972
14 46
Huebner, Robert, 1969-2002
15 1
Huebner, Robert (cont'd), 1969-2002
15 2
Huebner celebration, 11 November 1999
15 3
Hybridon - contract and approval, 1994-1996
15 4
ICN Pharmaceuticals, 1990-1991
15 5
Infectious Disease Society of America, 1990
15 6
Infu H5N1 DOD/NIAID, 2006-2007
15 7
Interpretation of serologic reactions in virology - DHEW, c.1965
15 8-9
Intracel, 2000-2001
15 10
Intramural Research Program, 1985-1987
15 11
Johns Hopkins Society of Scholars, 1999
15 12
Kapikian, Albert Z. [photographs], 1984
15 13
Krause, Richard M. - Director, NIAID, 1979-1981
15 14
Krause, Richard M. (cont'd), 24 March 1995
15 15
Laboratory methods in the diagnosis of viral exanthems - DHEW, c.1965
15 16
Laboratory of Viral Diseases - annual report, 1969
15 17
Laboratory of Infectious Diseases - history [35mm slides], 1992
15 18
Laboratory techniques in virology - DHEW, c.1965
15 19
Mattheis, Martha - Infectious Disease Branch, 1979-1984
 
MedImmune [subseries]:
15 20
General, 1998-2005
15 21-25
General (cont'd), 1998-2005
15 26
Adverse publicity, 1998
15 27
Biological materials license agreement, 1996
15 28-38
Meetings, 1989-2002
16 1-4
Meetings (cont'd), 1989-2002
16 5
Sales of Synagis, January-March 2000
16 6
Molecular Vaccines, Inc., 1988-1989
16 7
Monoclonal abs, RSV and otherwise, 1990-1994
16 8-14
Morris, Anthony, 1973-1978
16 15-16
Mycoplasma pneumonia and others, 1961-2002
16 17-27
National Academy of Sciences - Committee on International Security and Arms Control (CISAC), 1988-1997
17 1-8
National Academy of Sciences - Committee on International Security and Arms Control (CISAC) (cont'd), 1988-1997
17 9
National Academy of Sciences - Sabin, memoirs Rowe, 1998
17 10
National Cancer Institute - Frederick Cancer Research Facility Advisory Committee - meeting, 13 February 1987
17 11
NIAID Animal Care Committee, 1973-1980
17 12
NIAID Biodefense Research Agenda for Category B and C Priority Pathogens - progress report, 2004
17 13-14
NIAID Blue Ribbon Panel on Terrorism and its Implications for Biomedical Research, 2002
17 15-16
NIAID Clinical Research Subpanel, 1969-1980
18 1
NIAID Clinical Research Subpanel (cont'd)
18 2
NIAID Committee for Vaccine Development - correspondence, 1962-1967
18 3
NIAID Extramural Activities - report, 1968
18 4-6
NIAID Intramural Research Program - reports, 1968-1972
18 7
NIAID Laboratory Chiefs - meeting minutes, 2002-2005
18 8
NIAID Laboratory of Biology of Viruses - annual report, 1968
18 9
New York City Department of Health - laboratory analysis of 1957-1958 influenza outbreak in New York City, 1959
18 10-11
Pandemic avian flu - Secretary Leavitto's response for greater vaccine production from pharmaceutical manufacturers, 2006
18 12
Pandemic flu preparedness, 2001
18 13
Papilloma viruses, c.2000
18 14-15
Parainfluenza virus, 1998
18 16
Parainfluenza virus / glioma, 2004-2005
18 17
Pletnev 5 yr plan, 2004
18 18
Pneumonia, 1979
18 19
RSV and PIV3 high risk persons: RSV LID, 1991-1992
18 20-21
RSV pathogenesis acute and COPD (II), 1993
18 22-26
Rowe and Huebner [photographs], 1982-1998
18 27
Royal Danish academy of Sciences and letters - elected as foreign member, 1980
18 28-29
Russian TBEV collaboration, 2002
18 30-33
Sabin, Dr. Albert [photographs], 1964-2006
19 1-7
Sabin, Dr. Albert (cont'd), 1964-2006
19 8
Sabin poliovaccine [35mm slides], c.1986
19 9
Sabin poliovirus vaccine clinical field trials - final report, 1961
19 10
Sabin/Schlesinger dengue, 2003
19 11
Scripps Research Institute, 1987-1996
19 12
Seasonal and pandemic influenza, 2007
19 13
Sell, Kenneth W. - Scientific Director, NIAID, 1978-1984
19 14
Small pox, 2001-2006
19 15
Smorodintsev adenovirus vaccine, 1969
19 16
Society for Pediatric Research, 1993
19 17
Sugata, Fumihiko, 1993
19 18
Synagis, 1999-2001
19 19
Synergistic effect when two disparate mabs are used, 2002-2006
19 20
Tyrrell, D. A., Jr., 1970-1991
19 21
U.S. Public Health Service - technical report on Salk poliomyelitis vaccine, 1955
19 22
University of British Columbia, Dept. of Microbiology, Div. of Medical Microbiology - annual report, 1971
19 23
University of Maryland - prison studies hearing, 3 September 1975
 
Vaccine, 1958-2006 [subseries]:
19 24
Adenovirus vaccine program - business case analysis, c.2006
19 25
Vaccine development at the Laboratory of Infectious Diseases, c.2000
19 26
Current status of vaccines for prevention of respiratory syncytial virus infection in infants and children - Peter Wright, 2003
19 27
Licensed viral vaccines (U.S.A.), 1988
19 28-29
Rotavirus vaccines, 2000-2006
19 30
Virology Section - report, 1970
19 31
West Nile and Dengue, 2003
19 32
World Health Organization (WHO) - viral disease reports, 1958-1971
19 33
WHO Expert Advisory Panel on Virus Diseases, 1997
 
Presentations on 35mm Slides, 1961-2005 [subseries]:
19 34
Influenza Dearborn TS1[E], undated
19 35
Influenza TS1, undated
19 36-40
Mycoplasma, undated
20 1-2
PI Mpn epidem., undated
20 3
Poly IC study Knopp, undated
20 4
Respiratory Syncitial, undated
20 5
Respiratory Syncitial Coates, undated
20 6
Smith and Chanock Eaton vol, undated
20 7
Mycoplasma, 1961
20 8
Pneumonia, 1961
20 9
Respiratory Syncytial Mpn, 1961
20 10
Adeno caps PI, 1964
20 11-12
Mycoplasma, c.1965
20 13
Respiratory Syncytial and Para, c.1966
20 14
IOM priorities and Respiratory Syncytial Virus, 1966
20 15
Mycoplasma, c.1967
20 16
Mycoplasma Boston, 1967
20 17
Importance viruses and Mpn respiratory disease, 1968
20 18
Respiratory Syncytial temperature sensitive, 1968
20 19
Mycoplasma, 1969
20 20
Mycoplasma pneumoniae ASM, 1970
20 21
Mycoplasma, pneumonia, pap, 1970
20 22
PAHO, December 1970
20 23
Flu (temperature sensitive), 1971
20 24
Mycoplasma, 1971
20 25
Respiratory Syncytial Virus, 1971
20 26
Mycoplasma NY Acad., January 1973
20 27
Respiratory Syncytial, 1973
20 28
Animal rights, c.1979
20 29
Rotavirus, dengue, vaccines, etc., 1980-1981
20 30
Long-term goals and strategy of LID research / Sabin polio vaccine, 1986-1988
20 31
RSV, dengue, etc., c.1989
20 32
Respiratory Syncytial, 1989
20 33
Respiratory Syncytial Virus chimps and Respiratory Syncytial Virus summaries, 1990
20 34
Respiratory Syncytial Virus vaccines, 1990
20 35
Rotavirus, 1990
20 36
Respiratory Syncytial Virus mabs and fabs, 1990-1995
20 37
Respiratory Syncytial Virus, 1991
20 38
Respiratory Syncytial Virus, 1992-1993
20 39
Respiratory Syncytial Virus (cont'd), 1992-1993
20 40
St. Lucia - history of respiratory, December 2000
20 41
Parainfluenza viruses as vectors for the protective antigens of RSV and other respiratory viral antigens, 2004
20 42
Reverse genetic studies of the HMPV glycoproteins; Coronavirus vaccines; Respiratory syncytial virus vaccine development, 2005
 
Series 3: Lab Research, 1951-2008 [series]:
 
Lab Notebooks by researcher, 1958-2000 [subseries]:
21 1-2
Abinanti, Francis R., 1958-1964
21 3-19
Chanock, Robert M., 1958-2000
22 1-19
Chanock, Robert M. (cont'd), 1958-2000
23 1-19
Chanock, Robert M. (cont'd), 1958-2000
24 1-4
Chanock, Robert M. (cont'd), 1958-2000
24 5-8
Cook, M. Katherine, 1960-1975
24 9
Dans, Peter E., 1966-1967
24 10
Forsyth, Ben R., 1965-1966
24 11-18
Hoggan, M. David, 1972-1985
24 19
Johnson, Karl M., 1959-1962
25 1-3
Johnson, Karl M. (cont'd), 1959-1962
25 4-8
Kapikian, Albert Z., 1977-1981
25 9-10
Lewis, Marianne, 1972-1984
25 11-17
Mufson, Maurice A., 1962-1965
25 18-19
Rowe, Wallace P., 1958-1972
26 1-19
Rowe, Wallace P. (cont'd), 1958-1972
27 1-16
Rowe, Wallace P. (cont'd), 1958-1972
 
Lab Notebooks by Subject, 1954-1994 [subseries]:
27 17
CF Antigens, 1954-1975
27 18
Miscellaneous Virus, 1957
27 19
Neuraminidase, 1974-1993
28 1-8
Neuraminidase (cont'd), 1974-1993
28 9
Radioactive Materials, 1971-1974
28 10-16
Viral Reagents, 1962-1994
 
Research Data, 1950-2008 [subseries]:
28 17-19
Miscellaneous/Unidentified Studies, undated
29 1-7
Miscellaneous/Unidentified Studies (cont'd), 1950-2005
29 8
Japanese B encephalitis, 1951-1954
29 9
Lab studies on adenovirus, pneumonia or bronchiolites, 1952-1956
29 10
Avian Japanese B encephalitis, 1953-1955
29 11
Transplacental transmission polio virus, 1954-1955
29 12
Polio chick embryo, 1955
29 13
Yale - Monkey kidney trypsinization techniques Ph colon test, 1955-1956
29 14
Experiment 2. Assay of a high titer phage stock relation of plaque count to volume of phage suspension plated, 1956
29 15
Etiology of nonbacterial respiratory disease in infancy and childhood - NIH senior fellowship grant, 1956
29 16
Serology, 1956-1957
69 9
1 RSV collation, 1956-1957 [RESTRICTED PHI POLICY]
29 17
Croup, 1956-1959
29 18
Pap virus, 1958-1959
69 11
Mycoplasma - U.S. Naval Hospital, Beaufort, S.C. - patient summaries, 1959-1960 [RESTRICTED PHI POLICY]
29 19
Respiratory viruses and mycoplasmas clinical: Pap study - Parris Island, 1959-1961
29 20
#2 neutralization tests #19, 1959-1998
29 21
Immunization, 1961-1962
69 14-15
RS vaccine study, 1962-1975 [RESTRICTED PHI POLICY]
29 22
Contribution of adenoviruses to respiratory tract illness among children, 1963
29 23
Evaluation of WI-26 human diploid fibroblast cultures for isolation of adenovirus type 4, 1963
29 24-25
Lots of vaccine - Wyeth, 1963-1968
29 26-27
Mycoplasma, 1963-1992
29 28
Ludwig adeno capsule, 1964
29 29
Respiratory viruses and mycoplasmas clinical: adeno field trials - Parris Island, 1964-1965
30 1
Respiratory viruses and mycoplasmas clinical: m. pneumonia trials - Parris Island, 1965-1966
30 2
Respiratory viruses and mycoplasmas clinical: rs attenuated strain - 2, 1965-1970
69 18
Children's Hospital contract reports, 1965-1981 [RESTRICTED PHI POLICY]
30 3
Drug protocols - Wyeth, 1966
30 4
Respir. Viruses and mycoplasmas clinical: adeno field trials other, 1966-1967
69 17
RS vaccine study, 1967 [RESTRICTED PHI POLICY]
30 5
Experimental rubella vaccine lot 12-6/6A, 1967
30 6
Myxovirus recovery from respiratory tract illness - summary tables, 1967
30 7
Camargo, Ena - RSV - paraflu III plaque, 1967-1972
30 8-13
RS vaccine - Children's Hospital of D.C., 1967-1979
30 14-16
Production protocol - adenovirus vaccine, life, oral - type 7 - Wyeth, 1968-69
30 20
RS #3 challenge of para 1 new, November 1970
30 17
RS ts 1 mutant - Jessup, 30 December 1969
30 18
Clinical research protocols, 1969-1978
30 19
RS volunteer - wild type challenge of ts1 vaccinees, 13 February 1970
30 21
DBS-IND-294 Wyeth, adenovirus vaccine, type 7, live, oral - book 2, 1970-1972
30 22
Antibody response to m. pneumoniae vaccine, 1971
30 23
RSV clinical summary - Children's Hospital, 1971
30 24
Virus-associated immunopathology animal models and implications for human diseases, c.1972
30 25
RSV primates: to RS in children, c.1972-1973
69 23
Children's Hospital - nasal washings, 1972-1974 [RESTRICTED PHI POLICY]
30 26
Lab reports, 1973
30 27
Influenza A/1968 (H3N2) virus serum hemagglutination - inhibition antibody status of children before and after the Nov. 1972-Jan. 1973 epidemic of influenza A/1972 (H3N2) in Washington, D.C., 1973
30 28
Clinical observation of infants/children receiving RS-A2, ts-1 mutant, 1973
30 29
Mycoplasma vaccine trial (OSU-1) - Naval Medical Field Research Laboratory, 1974
30 30
Safety test protocol - A/Georgia/101/74 clone 1B, 1974
30 31
RS vaccine summaries - Children's Hospital, 1974-1975
31 1
RSV primates: bovine RSV in cotton rats, owl monkeys and chimps, 1974-1993
31 2
Swine influenza - Burroughs Wellcome Research Labs, 1975-1979
31 3
Camargo, Ena - RSV, 1975-1980
31 4
Huebner tumorigenicity TS-1-E (Morris), 1976
31 5
Status of two dose trials, 1976
31 6
Safety test - parainfluenza virus type 3, strain #22311 (lot F-367), 1976
31 7
RSV primates: genetic stability - stress tests RS, 1976-1989
31 8
Safety test of influ. A/VIC/3/75 (H3N2) x ts-1 [E], clone 81C1, recomb. virus (code CF/PP/1) - Flow Labs, 1977
31 9
Lot F-486 - RSV, strain A2, TS-1 NG-16 mutant, 1977-1979
31 10
RSV primates II, 1977-1991
31 11
Attenuated influenza vaccines, 1981
31 12
Nasal washings - Children's Hospital, 1981
31 13
RSV hr mutants in primates ts in primates: guinea pig kidney cell grown RSV - pass 18 chimps, 1981
31 14
RSV primates: cotton rat RS, 1981
31 15
RSV hr mutants in primates ts in primates: chick lung cell grown RSV passage 6 - chimps, 1982
31 16
RSV primates, 1982-1993
31 17
Research labs - Merck Sharp and Dohme, 1983-1991
31 18
SV40, 1983-2001
31 19-20
Production protocols - Wyeth, 1985
31 21
RSV hr mutants in primates ts in primates: primates studies RSV, 1986-1990
31 22
Immunization: flavi and alpha viruses, 1988
31 23
Prophylactic effect antibodies, 18 October 1988
31 24
MF59 Chiron, 1989-2006
31 25
RSV vaccine testing, 1989-2006
31 26
Fourth NIH rotavirus vaccine workshop, 5-6 November 1990
31 27
RSV ICN Krugman, 1991-1993
31 28
Flavivirus vaccine research - Walter Reed-NIAID, 1991-1994
31 29-30
RSV human fob monoclones, December 1991-February 1995
31 31
CA influenza virus - Wyeth, 1992-1993
31 32
RSV - Repligen, 1993
31 33
Fab 19 MARM, 1993-1995
31 34
RSV human FABS, 5 February 1995
31 35-36
AGMK cells, karyotype, tumor tests, patent, 1994-2000
32 1-3
Bovine RV (4x) clinical trial, 1997
32 4
U.S.-Russian collaboration final report, 1997
32 5-7
TBEV LGT, 1998-2000
32 8-9
TBEV II and West Nile, 2000
32 10
History of discovery and development of successful interventions, 2000
32 11
West Nile virus, 2000-2006
32 12
Periodic dengue, West Nile, TBEV meetings, 2001
32 13-14
Dengue vaccine part II, 2001-2007
33 13
Dengue virus and West Nile virus, 2008
32 15
Dengue virus vaccine development, 2002
33 1
TBEV and Langat II, 2002
33 2
Dengue virus vaccine data, 2003
33 3
Restoration of live adenoviruses vaccine in DOD, 2003-2005
33 4-6
Negative SV40, 2004
33 7-8
Positive SV40, 2004
33 9
Dengue virus vaccine development, 2004
33 10
Clinical WN/Den4 serology immunogenicity - clinical Lat/Den4 serology immunogenicity, 2005
33 11
Dengue candidates, August 2006
33 12
Den langat, 2006
 
LID Lab Research Reports, 1960-2004 [subseries]:
33 14-27
Clinical research projects, 1960-1982
33 28
NIAID ad hoc contract review, 1973
33 29
Experimental immunoprophylaxis against respiratory syncytial virus infections in primates, undated
33 30
Experimental infection of primates with respiratory syncytial virus, undated
33 31
Histological and virological study of the neurovirulence in rhesus monkeys of a langat/dengue 4 chimeric virus and its parental strains langat virus and dengue type 4 virus, undated
33 32
Virological analyses of recombinant, live, attenuated respiratory syncytial virus subgroup A strain rA2cp248/404/1030ΔSH in healthy unscreened 4-12 weeks old infants, undated
33 33
RNA tumor viruses as etiologic agents of solid tumors as well as leukemia - NIAID/NCI collaborative research, 1968
33 34
Determination of the effect of an inducer of interferon (IN-CN) administered to upper respiratory tract on experimentally induced respiratory virus infections, 1969
33 35
Safety of cold adapted respiratory syncytial virus vaccine in infants 6-7 months of age, 1969
33 36
Serum complement in acute bronchiolitis, 1969
33 37
Pediatric adenovirus vaccine evaluations, 1971
33 38
Fort Detrick reports, 1972-1977
34 1
Chanock scientific studies, 1973-1992
34 2
Transferring viruses to NIAID, 1997-1998
34 3
Development of a rotavirus vaccine for the prevention of severe rotavirus diarrhea of infants and young children - LID Epidemiology section, c.2000
34 4-5
Development of new approaches for vaccines against the tick-borne encephalitis virus complex - Molecular Viral Biology section, 2000-2001
34 6
Phase I study of Ad4-ΔE3-HIVenv and Ad4-ΔE3-HIV/gag/pro recombinant vaccines in HIV-negative volunteers, 2001
34 7
Projected schedule for WNV/DEN4 chimera studies, 2001
34 8
New molecular approaches to develop live attenuated vaccines against the tick-borne encephalitis complex and the West Nile encephalitis virus, 2003
34 9
The development of vaccines for parainfluenza virus types 1, 2, and 3 - Respiratory Viruses section, 2004
34 10
In vitro models of paramyxovirus infection, 2004
34 11
New molecular approaches to develop live attenuated vaccines against tick-borne encephalitis virus complex and the West Nile and St. Louis encephalitis viruses - Respiratory Viruses section, 2004
34 12
NIAID 69-A - Study of non-bacterial respiratory disease A) children, 1966-1969
34 13
NIAID 69-B - Non-bacterial respiratory disease in military recruits - epidemiology and experimental immunoprophylaxis, 1966
34 14
NIAID 69-C - The etiology of acute respiratory disease in civilian adults, 1965
34 15
NIAID 69-D - Collaborative studies of biophysical properties of respiratory viruses which are important to the development of vaccines, 1966
34 16
NIAID 70-A - Laboratory studies of newly r4ecognized viruses associated with respiratory illness, 1966
34 17
NIAID 70-B - Characterization of newly discovered rhinovirus serotypes of human origin, 1966
34 18
NIAID 70-C - Basic studies on mycoplasma, 1966
34 19
NIAID 70-C.1 - Serology and seroepidemiology of mycoplasmas (pleuropneumonia-like organisms - PPLO), 1966
34 20
NIAID 70-D - Laboratory studies of viral hepatitis agents, 1966
34 21
NIAID 70-E - Biological and biophysical studies of rhinoviruses, 1966-1969
34 22
NIAID 72-B - Study of respiratory viruses and mycoplasmas in human volunteers, 1969
 
Investigational New Drugs (IND), 1963-2001 [subseries]:
34 23
Unnumbered - Attenuated quadrivalent human-bovine (UK) rotavirus reassortant vaccine - original submission, 1995
34 24
Unnumbered - Wild-type and attenuated respiratory syncytial viruses; subgroup B, 1993
34 25
IND #24 - Parainfluenza type 3 vaccine - suppl. 1-4, 1963-1967
34 26-31
IND #71 - Live adenovirus type 4 enteric vaccine - suppl. 31-50, 1967-1972
34 32-35
IND #93 - Parainfluenza virus vaccines (types 1, 2, and 3) - suppl. 1-24, 1964-1973
35 1-2
IND #93 - Parainfluenza virus vaccines (types 1, 2, and 3) - suppl. 1-24 (cont'd), 1964-1973
35 3
IND #385 - Monovalent adenovirus type 2 soluble antigen vaccine, aqueous or alum absorbed - suppl. 1, 4-6, 1969-1971
35 4
IND #386 - Live, attenuated rubella virus vaccine strain HPV-79-RK 7, lot 31764 - suppl. 2-3, 1969
35 5
IND #401 - Meningococcal group C vaccine - suppl. 1-36, 1969-1973
35 6-7
IND #419 - Complexed polyinosinic and polycytidylic acids - suppl. 1-13, 1969-1970
35 8-9
IND #421 - Parainfluenza 3 challenge pool (attenuated?) - suppl. 1-23, 1969-1973
35 10
IND #437 - Pneumococcal polysaccharide vaccines, 1970-1972
35 11
IND #450 - Vaccinia virus vaccine -suppl. 7, 1971
35 12
IND #582 - H. Influenzae type b PRP vaccine - suppl. 10, 188, 1972-1987
35 13-20
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399, 1972-1995
36 1-17
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd), 1972-1995
37 1-18
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd), 1972-1995
38 1-18
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd), 1972-1995
39 1-18
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd), 1972-1995
40 1-18
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd), 1972-1995
41 1-3
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd), 1972-1995
41 4-5
IND #734 - TS mutants of mycoplasma pneumoniae - suppl. 1-1C (inactive), 1974-1977
41 6
IND #735 - Inactivated monovalent influenza B virus vaccine, 1973
41 7-8
IND #825 - Inactivated influenza A virus vaccines subunit - suppl. 1-30, 1974-1980
41 9
IND #839 - Poly I; poly C: poly-l-lysine - suppl. 1, 1974
41 10
IND #1044 - Live parainfluenza virus vaccines types 1, 2, and 3, placebo - suppl. 1-8 (inactive), 1975-1978
41 11-19
IND #1115 - Inactivated influenza A virus vaccines QA/NJ/1976 - suppl. 1-51, 1976-1980
42 1-6
IND #1115 - Inactivated influenza A virus vaccines QA/NJ/1976 - suppl. 1-51 (cont'd), 1976-1980
42 7
IND #1287 - Adenovirus subunit vaccines - suppl. 1-11, 1978-1982
42 8-17
IND #1298 - Inactivated influenza A virus vaccines (H1N1) - suppl. 1-118, 1978-1990
43 1-17
IND #1298 - Inactivated influenza A virus vaccines (H1N1) - suppl. 1-118 (cont'd), 1978-1990
43 18
IND #1384 - Live attenuated respiratory syncytial virus vaccine - suppl. 1-29, 37, 1979-1993
44 1-5
IND #1384 - Live attenuated respiratory syncytial virus vaccine - suppl. 1-29, 37 (cont'd), 1979-1993
44 6
IND #1462 - Varicella virus vaccine - suppl. 123, 1987
44 7-20
IND #1530 - Live human rotavirus (Wa strain, subgroup 2 [formerly type 2]) vaccine candidate - suppl. 1-125, 139, 1980-1998
45 1-15
IND #1530 - Live human rotavirus (Wa strain, subgroup 2 [formerly type 2]) vaccine candidate - suppl. 1-125, 139 (cont'd), 1980-1998
45 16
IND #1808 - E. coli CFA/II pili vaccine oral - suppl. 4, 1985
45 17
IND #1914 - Interferons - suppl. 9-10, 1985
45 18
IND #2000 - Vi capsular antigen - suppl. 4, 1985
45 19-21
IND #2843 - Live attenuated parainfluenza virus vaccines - supple 1-63, 1988-1995
46 1-7
IND #2843 - Live attenuated parainfluenza virus vaccines - supple 1-63 (cont'd), 1988-1995
46 8-10
IND #2858 - Bovine parainfluenza virus type 3 - suppl. 1-30, 1988-1994
46 11-14
IND #4006 - Rhesus rotavirus vaccines, live, (tetravalent, serotypes 1, 2, 3, and 4) oral - suppl. 1-25, 1988-1998
46 15-19
IND #4942 - Wild-type and attenuated respiratory syncytial viruses; subgroup A - suppl. 1-58, 1993-2000
47 1-5
IND #4942 - Wild-type and attenuated respiratory syncytial viruses; subgroup A - suppl. 1-58 (cont'd), 1993-2000
47 6-9
IND #4981 - Respiratory syncytial virus subgroup B (strain 14617, vero 1 cells) wild type and attenuated live vaccines - suppl. 1-33, 1993-2000
47 10
IND #7762 - Respiratory syncytial virus, live, attenuated vaccine and purified fusion protein with alum - suppl. 1-6, 8-9, 1998-2001
 
Research Contracts, 1952-2001 [subseries]:
 
Proposals, 1955-2001 [subseries]:
47 11
Unidentified, undated
47 12
Etiology of viral diarrheas - part III, undated
47 13
To obtain a recombinant form of type 1 poliomyelitis virus capable of multiplication in the embryonated egg, 1955
47 14
Assess antigenicity and effectiveness in infants and children of vaccines against newly discovered viruses responsible for respiratory tract illness. . ., c.1964
47 15
The isolation of viruses and viral subunits, 1964
47 16
Respiratory syncytial virus vaccine concentrated 100-fold from monkey kidney tissue cultures, c.1965
47 17
Studies on adenovirus vaccines, c.1965
47 18
Biochemical and immunologic investigations of neisseria meningitidis, 1965
47 19
Development of prototype, inactivated vaccines for respiratory syncytial and parainfluenza viruses and for mycoplasma pneumoniae, 1965
47 20
To assess the antigenicity and effectiveness in infants and children of vaccines against newly discovered viruses responsible for respiratory tract illness. . ., 1965
47 21
Concentration of human hepatitis virus (supplement to NIAID Support of Man program), 1966
47 22
Proposed vaccine studies, Kansas City, 1966
47 23
Respiratory virus vaccines, 1967
47 24
Tests in infants and children for antigenicity and effectiveness of inactivated vaccines, 1967
47 25
X-ray crystal structure of adenovirus coat protein, 1969
47 26
Respiratory viral vaccines and pathogenesis of respiratory viral disease in infants and children, 1971
47 27
Studies on hemophilus influenzae b vaccine, c.1972
47 28
Specific cell-mediated immunity to respiratory syncytial virus in infants and children following natural infection or immunization, 1974
47 29
Hybridization of highly radioactive adenovirus DNA strands with cancer DNA to detect viral DNA copies in human cancer cells, 1975
47 30
Evaluation of skin test reactivity during wild type and temperature sensitive influenza virus infection, 1975
47 31
Protective efficacy of langat virus vaccines in mice - animal study proposal, 1997
47 32
Evaluation of protective efficacy of dengue vaccines in mice - animal study proposal, 1999
47 33
Evaluation of chimeric TBEV/DEN4 virus vaccines in mice, 2001
47 34
Immunogenicity and protective efficacy of langat virus vaccines in mice, 2001
 
Reports, 1952-1998 [subseries]:
47 35-39
National Foundation for Infantile Paralysis - Children's Hospital, Cincinnati, 1952-1956
47 40
Vaccine development program commitments, 1965
47 41
Respiratory vaccine development, 1966
47 42
Induced upper respiratory tract infection of man with living adenovirus vaccine type 4, study #1, Lorton Reformatory, 1967
47 43
NIAID Molecular Anatomy Program, 1967
47 44
Evaluation of a live type 4 adenovirus vaccine, 1967-1968
47 45
Acute infectious nonbacterial gastroenteritis, 1973
47 46
103, 1169, 943 - Tissue culture and serology oncogenicity studies, RSV studies, 1964-1965
47 47
6-61-03-032 - Studies on virus and rickettsial diseases, 1953
47 48
263-81-C-0295 - Providing lung tissue, blood samples and nasal secretions, 1981
47 49
263-82-C-0037 - Providing lung tissue, blood samples and nasal secretions, 1981
47 50
3A014501B71Q - Communicable diseases - immunology, c.1966
47 51
DA-49-007-MD-950 - Comparison of aqueous and adjuvant adenovirus vaccines, 1963
47 52
DA-49-193-MD-2131 - Purification, characterization and synthesis of components of adenovirus, 1965
47 53
DA-49-193-MD-2189 - Studies on the etiology and epidemiology of acute respiratory infections, 1965
47 54
DA-49-193-MD-2495 - Genetic relationships among human and animal strains of influenza virus, 1967
47 55
DA-49-193-MD-2795 - Recombination and transmission studies with influenza virus, 1971
47 56
DADA-17-70-C-0121 - Purification, characterization, and synthesis of components of adenovirus, 1971
47 57
M4305.01-1011 BFG6; M4305.01-1012 BFG6 - Epidemiology and prevention fo acute respiratory disease in navy recruits, 1972
48 1
NIH-69-91 - Laboratory and antigenic studies of RSV; evaluation of respiratory syncytial, mimingococccal, and pneumococcal polysaccharide vaccines, 1970
48 2
NIH-69-2072 - Research and development of adenovirus vaccines and parainfluenza virus vaccines, 1970
48 3
NIH-69-2109 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illness, 1969
48 4
NIH-71-2091 - The assessment of antigenicity and effectiveness of respiratory disease vaccines, 1971
48 5-6
NIH-71-2196 - Respiratory viral vaccines and pathogenesis of respiratory viral disease in infants and children, 1971, 1973
48 7
N01-AI-01528 - New viruses in relation to clinical diseases, 1968-1972
48 8-9
N01-AI-02638 - Operation of a virus vaccine production laboratory, 1980-1981, 1983-1987
48 10
N01-AI-02653 - Center for the clinical testing of bacterial vaccines, respiratory virus vaccines and antivirals, 1981
48 11-13
N01-AI-05057 - University of Puerto Rico, 1991-1992
48 14-15
N01-AI-05067 - Care and housing of AIDS research animals, 1990-1991
48 16
N01-AI-17757 - Children's Hospital, 1980-1981
48 17-19
N01-AI-22503 - Clinical evaluation of respiratory viral and bacterial vaccines in children and adults, 1972-1989
48 20
N01-AI-22504 - Development of attenuated mutants of respiratory syncytial virus and parainfluenza viruses as potential vaccine strains, 1974
48 21
N01-AI-22508 - Clinical evaluation of influenza virus vaccines, 1974
48 22
N01-AI-35154 - Protocol relating to the passage, history, production, safety testing and characterization of an experimental live virus vaccine pool of influenza A/Beijing/352/89 (H3N2) . . ., 1993-1994
49 1-2
N01-AI-32521 - Operation of a virus laboratory in support of LID, 1974-1990
49 3-4
N01-AI-42510 - Preparation of isolated hemagglutinin, neuraminidase, matrix, and nucleoprotein subunits of influenza viruses and assay of their immunogenicity, 1978
49 5
N01-AI-42528 - Influenza research center, 1979
49 6
N01-AI-52565, 1985-1987
49 7-8
N01-AI-72535 - Establishment of an infectious enteric disease study, 1978-1979
49 9-10
N01-AI-82681 - Operation of an experimental virus vaccine production laboratory, 1988-1989
49 11
N01-AO-52703 - Care and housing of AIDS research animals, 1997-1998
49 12
N01-AO-52706 - Facility for non-human primates utilized in infectious disease research, 1998
49 13
PH-40-30-64 - Development of a technique for virus and viral subunit isolation from large volumes of tissue culture, 1966
49 14
PH-43-62-80 - Production of enterovirus antisera, 1965
49 15
PH-43-62-127 - Preparation of immune serum to enteroviruses, 1965
49 16
PH-43-62-129 - Standardization of picornavirus immune sera, 1965
49 17-26
PH-43-62-473; PH-43-66-917 - Antigenicity and protection studies on inactivated 100X concentrated RSV vaccine and inactivated 100X concentrated parainfluenza 1 virus vaccine, 1962-1970
49 27-29
PH-43-62-477 - Respiratory virus vaccine evaluation and surveillance, 1966-1968
49 30-32
PH-43-62-487 - Research and development of rhinovirus, mycoplasma pneumoniae, and RS vaccines, 1966-1968
49 33
PH-43-62-839 - Preparation of mycoplasma antigene and antisera, 1965
49 34-35
PH-43-63-75 - Respiratory disease surveillance and vaccine studies in military dependent children, 1968, 1970
49 36-38
PH-43-63-76 - Viral respiratory disease and immune response in the aged and in a pediatric population, 1966-1968
50 1-4
PH-43-63-79 - Research and development of adenovirus vaccines and parainfluenza virus vaccines and adaptation of RSV to embryonated eggs of several avian species, 1964-1966
50 5-6
PH-43-63-80 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illnesses, 1965, 1967
50 7
PH-43-63-81 - Development, growth and characterization of virus induced tumor cells, 1967
50 8
PH-43-63-90 - Upper respiratory virus, 1965
50 9
PH-43-63-103 - Operation of a serology and tissue culture developmental laboratory, 1966
50 10-11
PH-43-63-562 - Prevention of viral respiratory infections, 1964, 1968
50 12
PH-43-63-563 - Vaccine studies in a children's center, 1968
50 13
PH-43-63-564 - Research on attenuation of rhinoviruses and methods for measuring antibody response to rhinovirus infection, 1967
50 14-16
PH-43-63-582 - Respiratory disease vaccine, 1962-1967
50 17-18
PH-43-63-1128 - Surveillance of respiratory infections in an industrial population, 1966, 1968
50 19-20
PH-43-63-1141 - Surveillance of viral respiratory diseases and vaccine evaluation in a pediatric population, 1967-1968
50 21
PH-43-63-1163 - Studies on the response of primates to respiratory syncytial virus, 1964
50 22
PH-43-63-1174 - World Health Organization Reference Centre for Enteroviruses, 1965
50 23
PH-43-63-1177 - Reference seeds for echo and coxsackieviruses, 1965
50 24
PH-43-64-529 - Preparation and development of viral reagents, 1965
50 25-27
PH-43-64-928 - Molecular structure of oncogenic and non-oncogenic adenoviruses and the mechanism of viral carcinogenesis, 1966, 1968, 1972
50 28-29
PH-43-64-943 - Developmental study relating to the preparation of a respiratory syncytial virus vaccine, 1966-1967
50 30-32
PH-43-64-1169 - Oncogenicity testing of candidate viral respiratory vaccine strains and tumor reagent programs, 1965-1967
50 33-34
PH-43-65-562 - Rhinovirus reference laboratory, 1966-1967
50 35-36
PH-43-65-563 - Studies of RSV vaccines, 1966-1967
50 37
PH-43-65-1004 - Characterization and propagation of live rubella vaccine candidate strains and production reagents, 1968
50 38-40
PH-43-65-1031 - Study of vaccines for immunization against viral respiratory infections, 1966-1968
50 41
PH-43-66-63 - The testing of experimental respiratory agents and vaccines in volunteers, 1966
50 42-43
PH-43-66-93 - Rubella vaccine development, 1967-1968
50 44
PH-43-66-99 - Research on the feasibility of preparing inactivated and/or attenuated rubella virus vaccines, 1967
50 45
PH-43-66-459 - Research and development of attenuated and inactivated rubella vaccines, 1968
50 46-47
PH-43-66-461 - Research and development of an inactivated rubella virus vaccine, 1967-1968
50 48
PH-43-66-462 - Epidemiology of respiratory disease in total natural community and evaluation of immunizing agents, 1966
50 49
PH-43-66-464 - Studies on the detection of rubella virus and its immunogenicity for animals and man, 1966-1968
50 50
PH-43-66-565 - Development of a live vaccine for human influenza, 1966
50 51-52
PH-43-66-917 - The role of infection in precipitating sudden deaths in infants, 1969
50 53-54
PH-43-66-951 - Maintenance of a marmoset colony under strict isolation conditions, 1967-1968
50 55
PH-43-66-970 - Operation of a tissue culture developmental laboratory, 1967
50 56
PH-43-66-971 - Provide for the operation of a serology laboratory, 1967
50 57-58
PH-43-67-48 - Longitudinal studies of acute respiratory diseases in children, 1968, 1970
50 59-60
PH-43-67-75 - The testing of rubella virus vaccines in human volunteers, 1967-1968
50 61
PH-43-67-76 - Identification, characterization, purification and concentration of the antigens of respiratory syncytial virus, 1968
50 62
PH-43-67-77 - Biologic and antigenic studies with rubella virus, 1968
50 63
PH-43-67-78 - The influence of cultural conditions and concentration procedures on the antigenicity of mycoplasma pneumoniae vaccines, 1968
50 64-65
PH-43-67-79 - Study of the antigenicity and immunogenicity of mycoplasma pneumoniae vaccines, 1967
50 66
PH-43-67-80 - Studies of rubella vaccine efficacy, 1967
50 67
PH-43-67-91 - Research and development of respiratory disease vaccines, 1967-1968
50 68
PH-43-67-681 - Surveillance of pneumococcal infection for field trials of polyvalent pneumococcal vaccines, 1973
50 69
PH-43-67-692 - Search for virus-specific genetic material in human cancers and studies on the mechanism of viral carcinogenesis, 1969
50 70-71
PH-43-67-745 - Studies of local antibody in respiratory viral immunity, 1967, 1969
50 72
PH-43-68-81 - Operation of a rubella virus service laboratory, 1968
50 73
PH-43-68-83 - Primary immunization of infants with group A streptococcal M protein, 1968
50 74
PH-43-68-692 - Research and development of rhinovirus and mycoplasma pneumoniae vaccines, 1968
51 1-4
PH-43-68-1309 - Development of chemically induced conditional-lethal temperature-sensitive (ts) mutants of RS and parainfluenza viruses, 1968-1975
51 5-6
PH-43-68-1316 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illness, 1968-1969
51 7
Z01-AI-00024 - Laboratory studies of myxoviruses, paramyxoviruses and respiratory syncytial virus, 1977
51 8
Z01-AI-00175 - Laboratory studies of paramyxoviruses and respiratory snycytial virus, 1978-1981
 
Cooperative Research and Development Agreements (CRADA), 1972-2003 [subseries]:
51 9
License agreements, 1988-1996
51 10-11
Chiron, 1988-2003
51 12-15
Intracel, 1995-1997
51 16-21
Lederle, 1992-2000
52 1-10
Lederle (cont'd), 1992-2000
52 11
MedImmune, 2002
52 12
Praxis, 1987-1988
52 13
Upjohn, 1988
52 14-27
Wyeth, 1972-2001
53 1-5
Wyeth (cont'd), 1972-2001
 
Series 4: Patents, 1966-2008 [series]:
53 6-7
Chanock's patents, 1967-2000
53 8-10
Patent status reports, 2002-2008
53 11
Confluent growth of mycoplasma - application, 1966-1967
53 12-15
#3,317,393 - Immunization by selective infection of the intestinal tract with an encapsulated live virus, 1967-2005
53 16-17
#3,992,522 - Temperature sensitive recombinant mutant viruses and a process for producing same, 1974-1976
53 18
#4,552,757 - Use in an animal host and precursors for vaccines utilizing avian-human reassortants to combat influenza A virus, 1984-1988
53 19-20
#4,571,385 - Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors, 1995-1999
53 21-29
#4,704,275 - Vaccine against rotavirus diseases (RotaShield - RRV-TV - Wyeth), 1998-2005
54 1-4
#4,704,275 - Vaccine against rotavirus diseases (RotaShield - RRV-TV - Wyeth) (cont'd), 1998-2005
54 5
#4,751,080 - Vaccine against rotavirus diseases, 1988
54 6-9
#4,800,078 - Immunotherapeutic method of treating respiratory disease by intranasal administration of IGB, 1966-1993
54 10
#5,646,033 - African green monkey kidney cell lines useful for maintaining viruses and for preparation of viral vaccines, 1997
54 11-18
#5,762,905 - Human neutralizing monoclonal antibodies to respiratory syncytial virus, 1995-2004
54 19
#5,882,651 - Attenuated respiratory syncytial virus vaccine compositions, 1993
54 20
#5,911,998 - Method of producing a virus vaccine from an African green monkey kidney cell line, 1999
54 21
#5,922,326 - Attenuated respiratory snycytial virus vaccine compositions, 1993
54 22
#6,117,667 - Method for producing an adapted virus population from an African green monkey kidney cell line, 2000
54 23-33
#6,184,024 - Chimeric and/or growth restricted flaviviruses, 1992-2007
55 1-2
#6,184,024 - Chimeric and/or growth restricted flaviviruses (cont'd), 1992-2007
55 3-9
#6,497,884 - Chimeric vaccine against tick-borne encephalitis virus, 2000-2007
55 10
#6,660,273 - Chimeric vaccine against tick-borne encephalitis virus, 2003
55 11-12
#6,676,936 - Chimeric and/or growth-restricted flaviviruses, 1998-1999
55 13-19
#6,794,174 - Full-length infectious cDNA clones of tick-borne flavivirus, 2001-2008
55 20
#7,150,984 - Attenuated human rotavirus vaccine, 2006
55 21
#7,364,737 - Human neutralizing monoclonal antibodies to respiratory syncytial virus, 2008
55 22-25
#7,932,074 - Multivalent human-bovine rotavirus vaccine, 1998-2006
55 26-28
#8,778,671 - Construction of West Nile virus and dengue fever chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus, 2001-2004
 
Series 5: Writings/Reprints, 1953-2007 [series]:
55 29
Chanock numbered bibliography (1-653), 2003
 
Numbered Articles by Dr. Chanock, 1953-2003 [subseries]:
55 30-34
1-5, 1953-1954
56 1-144
6-151 [incomplete], 1954-1967

[missing 127, 149]

57 1-148
152-323 [incomplete], 1967-1976

[missing 169, 194, 200, 203, 209, 219, 221, 230, 236, 247, 250, 252-253, 257, 259, 290, 291, 293-295, 301, 310, 315, 319]

58 1-194
325-568 [incomplete], 1976-1989

[missing 330, 340, 342, 348, 350, 364, 370, 384, 396, 411, 443-444, 449-450, 460, 464-465, 467, 470, 471, 474-477, 479, 481-482, 502-503, 505, 509, 524-525, 527, 532, 534, 537, 540-542, 546, 551-552, 557-558, 560, 563-566]

59 1-46
570-653 [incomplete], 1989-2003

[missing 574, 576, 579-581, 584, 586, 589-594, 597-600, 602, 605, 608, 611-612, 615, 618, 620-623, 625, 629-630, 641-644, 647-649]

 
Unnumbered Reprints by Dr. Chanock, 1954-2005 [subseries]:
59 47
Respiratory syncytial vaccine - with Murphy, Collins, and Olmsted, undated
59 48
Recovery and characterization of hemagglutinins from two immunologically distinct types of dengue virus - with Sabin and Sweet, c.1954
59 49
III. Production of illness and clinical observations in adult volunteers, 1961
59 50
Primary atypical pneumonia, 1966
59 51
Genetic approaches to the prevention of influenza A virus infection - with Murphy, 1981
59 52
Strain-specific serum antibody response in infants undergoing primary infection with respiratory syncytial virus - with Hendry, Burns, Walsh, Graham, Wright, Hemming, Rodriguez, Kim, Prince, McIntosh, and Murphy, 1988
59 53
Antigenic analysis of the dengue virus envelope glycoprotein using synthetic peptides - with Markoff, Bray, Lai, Eckels, Summers, Gentry, Houghten, and Lerner, 1988
59 54
Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys - with Rumyantsev, Murphy, and Pletnev, 2005
 
Drafts by Dr. Chanock, c.1960s-c.2007 [subseries]:
59 55
Untitled fragments, undated
59 56
Acute respiratory disease of infancy and childhood - present understanding and prospects for prevention, undated
59 57
Blueprint for use of live virus vaccine to prevent a pandemic of influenza A virus - with Murphy and Spring, undated
59 58
Decreased virulence and protective effect of a genetically stable temperature-sensitive mutant of m. pneumoniae in human volunteers, undated
59 59
Infection of immature white mice by the addition of western equine encephalitis virus to the feed, undated
59 60
Parainfluenza, respiratory syncytial, and New Castle disease viruses - with Parrott (title page only), undated
59 61
Development of immunity - outline, c.1960s
59 62
Prospects for control of auto viral mycoplasmal respiratory tract disease by vaccination, c.1960s
59 63
Untitled draft re pediatric respiratory illnesses at Camp Lejeune 1959-1963, c.1964
59 64
The contribution of adenoviruses to respiratory tract illness among children, c.1965
59 65
The relationship of mycoplasma pneumoniae to pediatric respiratory tract disease - with Canchola, Brandt, Kim, and Parrott, 1970
59 66
Guide for the collection and transport of virological specimens, 1975
59 67
Virus and mycoplasma pneumoniae in respiratory disease patients, January 1975-June 1976 - with Brandt, Kim, Arrobio, and Parrott, c.1977
59 68
Isolation and characterization of temperature-sensitive mutants of influenza A virus, 1977
59 69
Bovine respiratory syncytial virus: studies in experimental animals - with Prince, Suffin, Horswood, Camargo, Prevar, and Sly, 1980
59 70
Respiratory syncytial virus in cotton rats: growth, antigenicity and protective efficacy of two temperature-sensitive, live virus vaccine candidates, ts-1-NG-1 and ts-1-NG-16 - with Prince, Horswood, Prevar, Camargo, Suffin, and Spring, 1980
59 71
HLA antigens in severe respiratory syncytial virus disease in infants and early childhood - with Johnson, Kiim, Hartzman, Parrott, Woody, and Sell, 1981
59 72
Studies of avian-human reassortant influenza A viruses in seronegative (HAE<1:8) adult volunteers, 1984-86 - with Clements, Murphy, Snyder, Buckler-White, Tierney, Betts, Dolin, Black, and Sears, 1986
59 73
Respiratory syncytial virus: thirty-five year status report on research achievements, opportunities and frustrations, 1991
59 74
A live cold-passaged temperature-sensitive mutant of human respiratory syncytial virus is highly attenuated, genetically stable, immunogenic, and efficacious against wild type challenge in seronegative chimpanzees, 1993
59 75
"Cold-passaged and temperature sensitive (ts) derivatives of the partially attenuated respiratory syncytial virus ts-4 mutant are more restricted in replication in mice - with Crowe, Jr., Hsu, Lubeck, and Murphy, c.1994
59 76
Short summary of studies of chimeric viruses as candidates for live attenuated vaccine against tick-borne encephalitis, 2000-2005
59 77
Comparison of live and inactivated tick-borne encephalitis virus vaccines for immunogenicity and efficacy in rhesus monkeys - with Rumyantsev, Murphy, and Pletnev, 2005
59 78
Early experiences with influenza adjuvated vaccines, c.2007
 
Untitled Drafts by Dr. Chanock, c.1955-c.2007 [subseries]:
59 79
Miscellaneous individual pages, undated
59 80
The interplay of immunologic factors in acute viral respiratory tract disease, undated
59 81
pages 16-22 re ts mutants, undated
59 82
There is compelling evidence that local immunity plays a major role in resistance to most respiratory viral pathogens, undated
59 83
re temperature-sensitive mutants, undated
59 84
re vaccines against RSV, undated
59 85
re arthropod-borne encephalitis viruses, c.1955
59 86
pages 3-15 re RS virus, c.1962
59 87
report on tests of inactivated respiratory virus vaccines, c.1967-1968
59 88
mycoplasma pneumoniae, 1973
59 89
RS virus (RSV) is the major viral pathogen of the respiratory tract, 1975
59 90
Respiratory syncytial (RS) virus is the major etiologic agent of bronchiolitis, 1976
59 91
pages 25-90 of "f-rot.doc", 1989
59 92
Evaluation of antibody response to RSV, 1990
59 93
pages 9-29 re serum RSV antibodies, c.1994
59 94
re vaccine against TBEV, c.2002
59 95
re Langat virus (LGT) - with Kyle, 2002
59 96
re flaviviridae tick-borne encephalitis viruses (TBEV), 2004
59 97
re protective immune response against 1918 influenza virus, c.2007
 
Books Inscribed to Dr. Chanock, 1998-2004 [subseries]:
60 1
Textbook of Military Medicine - Part I Warfare, Weaponry and the Casualty, 1998
60 2
Hantavirus hunting - by Ho-Wang Lee, 2004
 
Series 6: Meetings, 1954-2005 [series]:
60 3
Proceedings of the Conference on Complement Fixation, 5 August 1954
60 4-5
Proceedings of the Conference on Neutralization, 18-20 May 1955
60 6
Proceedings of the Round Table Conference on Genetic Aspects of Virus-Host Cell Relationships with Particular Reference to Polioviruses, 23-24 February 1956
60 7
Society for Pediatric Research annual meeting, 8-9 May 1959
60 8
Meetings - general, 1960
60 9
Meetings - general, 1961
60 10-11
Russian trip, May 1961
60 12
Meeting in Prague, Czechoslovakia, 23-27 May 1961
60 13
World Health Organization, Geneva, 15-21 August 1961
60 14
Meetings - general, 1962
60 15
International Postgraduate Course Respiratory Virus Diseases, 11-14 April 1962
60 16
Newer Respiratory Disease Viruses, 3 October 1962
60 17
Meetings - general, 1963
60 18
World Health Organization Respiratory Virus meeting, 1-6 July 1963
60 19
University of Wisconsin Symposium on New Castle Disease, 15 July 1963
60 20
7th International Congress on Tropical Medicine, 1-11 September 1963
60 21
Seminar on Respiratory Disease, 9 October 1963
60 22
Meetings - general, 1964
60 23
American College of Physicians, 6-10 April 1964
60 24
World Health Organization directors, 20-27 July 1964
60 25
Meetings - general, 1965
60 26
Rhinovirus workshop, 25 January 1965
60 27
American Society of Clinical Investigation, 3 May 1965
60 28
World Health Organization, 27 September 1965
60 29
Armed Forces Epidemiological Board Commission on Viral Infections, 14-15 October 1965
60 30
International Congress of Pediatrics, 7 November 1965
60 31
Conference on Acute Infectioius Respiratory Diseases, 14-15 December 1965
60 32
Meetings - general, 1966
60 33
Mycoplasma conference, 9-11 February 1966
60 34
American Society for Clinical Investigation, 1 May 1966
60 35
New York Academy of Science, 11 May 1966
60 36
Conference on Live Oral Adenovirus Vaccine in Marine and Navy Recruits, 10-11 June 1966
61 1
Pan American Health Organization, 7 November 1966
61 2
Meetings - general, 1967
61 3-4
Human Vaccines - Possible Oncogenic Implications, 9 January 1967
61 5
Laboratory Methods in the Isolation and Identification of Respiroviruses and Enteroviruses, 3-4 July 1967
61 6
Respiratory Syncytial Virus Workshop, 10 July 1967
61 7
Conference on Measles Virus, etc., 13 September 1967
61 8
Scientific Group on Respiratory Viruses, 9-14 October 1967
61 9
American Academy of Pediatrics, 25 October 1967
61 10
Symposium honoring Dr. M. D. Eaton, 1 December 1966
61 11
Meetings - general, 1968
61 12
Clinical at the College of Physicians and Surgeons, Columbia, University, 27 January 1968
61 13-14
Gustav Stern Symposium on Perspectives in Virology, 29 January 1968
61 15
American Academy of Allergy, 5-7 February 1968
61 16
American Epidemiological Society, 29-30 March 1968
61 17
American Medical Association, 23-24 April 1968
61 18
American Society for Clinical Investigation, 5 May 1968
61 19
Society for Epidemiological Research, 10-11 May 1968
61 20
Postgraduate Workshop, University of Maryland, 2 June 1968
61 21
Third International Symposium on Aerobiology, 15-19 September 1968
61 22
Influenza Genetics, 11-12 November 1968
61 23
Armed Forces Epidemiological Board Committee on Influenza, 18-20 November 1968
61 24
Twelfth International Congress of Pediatrics, 1-7 December 1968
61 25
Meetings - general, 1969
61 26
Vaccine Development Committee meeting, 27-28 January 1969
61 27
International Conference on Rubella Immunizations, 18-20 February 1969
61 28
Conference on Immunology, 2 April 1969
61 29-30
World Health Organization Virus Reference Centres meeting, 22-25 April 1969
61 31
American Society for Microbiology, 4-9 May 1969
61 32
American Society for Clinical Investigation, 5 May 1969
61 33
American Thoracic Society, 24-26 May 1969
61 34
Gustav Stern meeting, 25-26 May 1969
61 35
Ad hoc Conference on Australia Antigen and Hepatitis, 23-24 June 1969
61 36
Vaccine Development Workshop on Vaccine Testings, 27 June 1969
61 37
Virus Diseases of the Respiratory Tract, 23 September 1969
61 38
International Working Conference on Influenza, 14-16 October 1969
61 39
Infectious Disease Society of America, 25-26 October 1969
61 40
International Conference on Vaccines against Viral and Rickettsial Diseases of Man, 7-11 November 1969
61 41
Committee on Influenza, 17-19 November 1969
61 42
NICHD Immunology Workshop, 11-13 December 1969
61 43
Secretory Antibody, 10-13 December 1969
61 44
Human Responses to Viral Antigens, 3 August 1971
61 45
Mycoplasma and Mycoplasma-like Agents of Animal and Plant Diseases, 8-10 January 1973
61 46
Influenza Workshop IV, 24 January 1973
61 47
Acute Respiratory Diseases, 8-9 March 1973
61 48
Influenza Vaccines, University of Maryland, 13 March 1973
61 49
Fogarty Center Conferences on Preventive Medicine, 15-16 March 1973
61 50
ICN/UCLA Symposium on Molecular Biology-Virus Research, 18-23 March 1973
61 51
New Approaches for Inducing Natural Immunity to Pyogenic Organisms, 20-23 March 1973
61 52
Influenza Workshop V on Influenza Vaccines, 3-4, 14 April 1973
62 1
Influenza Workshop V on Influenza Vaccines (cont'd), 3-4, 14 April 1973
62 2
American Epidemiological Society, 6-7 April 1973
62 3
Epidemic Intelligence Service Conference, 9-13 April 1973
62 4-5
Directors of World Health Organization Reference Centers, 16-19 April 1973
62 6
U.S.-Japan Program, 23-27 July 1973
62 7-8
Problems of Bacteriophage Contamination, 1 August 1973
62 9
FIC Subcommittee on Infectious Diseases, 14-16 September 1973
62 10
Infectious Diseases Society of America, 17-18 September 1973
62 11
Parainfluenza and RS Candidate Vaccines, 5 October 1973
62 12
Animal Influenza and its Significance for Human Infections, 11-12 October 1973
62 13
University of Chicago Alumni Banquet, 23 October 1973
62 14
National Academy of Sciences, 23 October 1973
62 15
Interagency Meeting on Influenza, 19 November 1973
62 16-17
World Health Organization, 1-5 September 1975
62 18
Joint Working Conference of the Virus Cancer Program, 3-5 November 1975
62 19
Influenza meeting, NIH, 12 January 1976
62 20
Influenza Program Review meeting, NIH, 15-16 January 1976
62 21
Working Group on Pandemic Influenza, 26-28 January 1976
62 22
Bacterial and Viral Gastroenteritis, 5-6 February 1976
62 23
Bureau of Biologics, 20 February 1976
62 24
Walter Reed Ad Hoc meeting, 8 March 1976
62 25
Armed Forces Epidemiological Board, 12 March 1976
62 26
Bureau of Biologics, 25 March 1976
62 27
Current Status and Prospect for Improved and New Bacterial Vaccines, 29 March-1 April 1976
62 28
Influenza meeting, NIH, 15 April 1976
62 29
National Academy of Sciences, 26-28 April 1976
62 30
American Epidemiological Society, 29 April-1 May 1976
62 31
Association of American Physicians, 30 April-2 May 1976
62 32
American Society for Microbiology, 2-7 May 1976
62 33
Association of American Physicians, 4 May 1976
62 34
Conference on Persistent Viral Infections, 13-16 June 1976
62 35
Bureau of Biologics, 21-22 June 1976
62 36
Bronchiolitis workshop, 28-29 June 1976
62 37
Festschrift for Albert Sabin, 26 August 1976
62 38
Consensus Development on Use of Amantadine, 15-16 October 1976
62 39
Infectious Disease Society of America, 25-26 October 1976
62 40
Ad Hoc Viral and Rickettsial Disease Study Group, 8 November 1976
62 41
Viral and Bacterial Vaccines, Present Knowledge and Future Development International Symposium, 7-8 September 1977
62 42
Chinese delegation, 1979
62 43
Experimental Herpesvirus Vaccine workshop, 7-9 February 1979
62 44
Surgeon General's Meeting on Influenza, 12 February 1979
62 45
Medical Research Council, 20 February 1979
62 46
Symposium on Potentiation of Immune Response to Vaccines, 20-21 February 1979
62 47
The Royal Society Meeting on Influenza, 21-22 February 1979
63 1
Secretary's Conference on Influenza, 6 March 1979
63 2
Attenuated Influenza Vaccine workshop, NIH, 9 March 1979
63 3
American Physicians Fellowship Program, NIH, 29-30 March 1979
63 4
American Epidemiological Society, 30-31 March 1979
63 5
Vaccine Studies in the Elderly, 30 April 1979
63 6
American Society for Microbiology, 4-11 May 1979
63 7
Influenza B Viruses workshop, 30-31, 1979
63 8
Prevention of Major Infectious Diseases: Current Concerns and Future Promise, 20-21 September 1979
63 9
Medical Society of the District of Columbia, 27-28 September 1979
63 10
Infectious Diseases Society of America, 5-6 October 1979
63 11
Molecular Approaches to Vaccine Development, 10 October 1979
63 12
U.S.-U.S.S.R. Influenza meeting, 16-18 October 1979
63 13
Genetic Variation of Viruses, 28-30 November 1979
63 14
Australian Commonwealth Scientific and Industrial Research Organization, 10-12 December 1979
63 15
Perspectives in Virology, 4-5 February 1980
63 16
Australian Academy of Science, 8-12 February 1982
63 17
Duke University seminar, 4 February 1980
63 18
Attenuated Vaccines, 10 March 1980
63 19
Pritzker School of Medicine Council meeting, 2 May 1980
63 20
American Society for Microbiology, 11-16 May 1980
63 21
Eradication of Infectious Diseases, 27-28 May 1980
63 22
Infectious Disease Society of America, 25-26 September 1980
63 23
Negative Strand Viruses, 27 October-1 November 1980
63 24
World Health Organization Consultation on Influenza, 5-6 November 1980
63 25
Department of Microbiology and Molecular Genetics seminar, 2 December 1980
63 26
ICN/UCLA Symposium on Genetic Variation of Influenza Viruses, 8-13 March 1981
63 27
International Symposium on Viral Hepatitis, 30 March-2 April 1981
63 28
Department of Microbiology and Immunology seminar, Duke University, 16 April 1981
63 29
Mt. Sinai Symposium on Infections Caused by Enteric Viruses, 4 June 1981
63 30
International Congress of Virology, 2-7 August 1981
63 31
Respiratory Diseases meeting, 16 October 1981
63 32
Workshop on Respiratory Diseases, 21-22 June 1982
63 33
International Symposium on Polilomyelitis Control, 14-17 March 1983
63 34
NIAID Workshop on AIDS, 5-6 April 1983
63 35
Towards New Vaccines Against Virus Infections, 21-23 June 1983
63 36
London Conference on Influenza, 21-23 September 1983
63 37
Association of American Physicians, 29 April-2 May 1983
63 38-47
Modern Approaches to Vaccine, 31 August-4 September 1983
63 48
Negative Strand Virus meeting, 11-17 September 1983
63 49
International Conference on Immunobiology and Prophylaxis of Human Herpesvirus Infections, 9-12 October 1983
63 50
19th Immunization Conference - proceedings, 21-24 May 1984
63 51
International Congress of Virology, 1-7 September 1984
63 52
International Workshop on the Molecular Biology of Flaviviruses, 29 November-1 December 1984
63 53
Status of Attenuated Influenza Vaccines, 10-11 December 1984
63 54
Rowe Symposium, 11-12 February 1985
63 55
Rotavirus Vaccine Work Group, 13 March 1985
63 56
Genetically Altered Viruses, 28 April-1 May 1985
64 1
American Society for Virology, 21-25 July 1985
64 2
World Health Organization Steering Committee on Acute Respiratory Viruses, 29-30 July 1985
64 3-5
Modern Approaches to Vaccines, 11-15 September 1985
64 6
The Biology of Negative Strand Viruses, 15-20 September 1985
64 7
Expression of Foreign Genes, 4-7 October 1985
64 8
RSV Symposium, 16 October 1985
64 9
Duke University Academic Visiting Professor, 16-18 December 1985
64 10
Scripps Scientific Review Committee, 13-15 January 1986
64 11
Rowe Symposium, 3-4 February 1986
64 12
Vaccinia-Vectoring, 31 March 1986
64 13
Cosmos Club award, Albert Sabin, 15 April 1986
64 14
Vaccine Supply and Innovation workshop, 24-25 April 1986
64 15
Association of American Physicians, 2-4 Mary 1986
64 16
Influenza Viruses, 20 May 1986
64 17
World Health Organization Acute Respiratory Viruses meeting, 27-28 June 1986
64 18
FEBS meeting, 24-29 August 1986
64 19
Infectious Diseases Society of America, 2-3 October 1986
64 20
Scripps Scientific Review Committee, 10 January 1987
64 21
Rowe Symposium, 2-3 February 1987
64 22
AIDS Vaccines workshop, 25-27 March 1987
64 23
Workshop on Respiratory Syncytial and Parainfluenza Viruses, 4-5 May 1987
64 24
Scholars-in-Residence symposium, 11-14 May 1987
64 25
Pasteur Centenary Symposium, 26-28 May 1987
64 26
American Society for Virology, 31 May-4 June 1987
64 27
International Conference on AIDS, 1-5 June 1987
64 28-29
Nobel Symposium on the Vaccines of the Future, 23-26 August 1987
64 30
International Symposium on Infectious Diseases, 11-12 November 1987
64 31
Live Viral Vaccines for Respiratory and Enteric Tract Diseases, 24 November 1987
64 32
Conference on the Development of Vaccines Against HIV and AIDS, 14-15 December 1987
64 33
Scripps Scientific Review Committee, 14 January 1988
64 34
Conference on Poliomyelitis Vaccines: Re-evaluating Policy Options, 21-22 January 1988
64 35
Rowe Symposium, 1-2 February 1988
64 36
National Academy of Sciences Committee on International Security and Arms Control, 16 March 1988
64 37
Oral Immunization symposium, 21-22 March 1988
64 38
NIH Seminar, 6 April 1988
64 39
American Pediatric Society Centennial Celebration, 3 May 1988
64 40
National Academy of Sciences and Academy of Sciences of the USSR on Biological Weapons, 9-11 May 1988
64 41
Wagner Symposium, 15-16 May 1988
64 42
Live Attenuated Influenza Virus Vaccine, 26 May 1988
64 43
American Society for Virology, 12-16 June 1988
64 44
NIH Rotavirus Vaccine workshop, 8-9 September 1988
64 45
Modern Approaches to New Vaccines Including Prevention of AIDS, 14-18 September 1988
64 46
Immunology of Virus Diseases, 26-28 October 1988
64 47
Genetic Basis of Human Disease, 30 November-1 December 1988
64 48
Institute of Medicine Research Briefing Panel, 27-28 April 1989
64 49
Symposium on Respiratory Virus Vaccine Development, 1 May 1989
64 50
American Society for Virology, 9-13 July 1989
64 51-52
Modern Approaches to New Vaccines Including Prevention of AIDS, 20-24 September 1989
64 53
International Conference on Comparative and Applied Virology, 15-21 October 1989
64 54
Rowe Symposium, 5-6 February 1989
64 55-56
American Thoracic Society, 23 May 1990
65 1
American Thoracic Society (cont'd), 23 May 1990
65 2
International Congress of Virology, 26-31 August 1990
65 3
Children's Vaccine Initiative, 6 August 1990
65 4
Colloquium on Human Diseases - Molecular Mechanisms of Viral Pathogenesis, 19-20 October 1990
65 5
Animal Models of Respiratory Syncytial Virus Infections, 24-25 October 1990
65 6
NIH Rotavirus Vaccine Workshop, 5-6 November 1990
65 7
Rowe Symposium, 4-5 February 1991
65 8
Saul Krugman Festschrift, 12 April 1991
65 9
Inauguration of Richard M. Haidack Distinguished Professorship in Medicine, 29 May 1991
65 10
Pathogenesis Symposium, 5 December 1991
65 11
Rowe Symposium, 3-4 February 1992
65 12
NIAID Interdivisional AIDS Working Group, 24 April 1992
65 13
Measles workshop, 14-15 September 1992
65 14
Lounsbury Award Jury Dinner, 5 November 1992
65 15
Innovations in Therapy of Human Viral Diseases, 6-7 December 1992
65 16
Molecular Pathogenesis of Infections and Tumors, 5-6 May 1994
65 17
Scientific Symposium to Honor the Work of Janet W. Hartley, 13 September 1994
65 18
Scientific Meeting of the Australian Society for Microbiology, 26-30 September 1994
65 19
Molecular Approaches to the Control of Infectious Diseases, 5-9 October 1994
65 20-21
Frank and Bobbie Fenner Conference in Medical Research, 28-30 November 1994
65 22
Office of Science and Technology Policy meeting, 29 March 1995
65 23
Fogarty Advisory Board, 23 May 1995
65 24
Igor Tamm Memorial Symposium, 30 November 1995
65 25
Thomas Merigan Lecture, 23-29 May 1996
65 26
Conference on Immunoglobulins, 2-4 June 1996
65 27
Antibody workshop, 2-4 June 1996
65 28
Simian Virus 40 workshop, 27-28 January 1997
65 29-30
NIAID Principal Investigators' retreat, 20-21 November 1997
65 31
Center for Biologics Evaluation and Research, Vaccines and Related Biological Products Advisory Committee, 19-20 Novebmer 1998
65 32
American Epidemiological Society, 18-19 March 1999
65 33
Memorial Symposium for Robert Huebner, 11 November 1999
65 34
Conference on Vaccine Research, 1-2 May 2000
65 35
NIAID Principal Investigators' workshop, 6-7 November 2000
65 36
NIAID Principal Investigators' workshop, 14-15 November 2002
65 37
RSV 2003 Symposium, 8-11 November 2003
65 38
Trans-NIH/FDA Intramural Biodefense Symposium, 7-8 April 2004
65 39
Rotavirus Symposium, 7-9 July 2005
65 40
RSV Symposium, 15-18 September 2005
 
Series 7: Lectures and Speeches, 1951-2005 [series]:
65 41
Control of pediatric viral diseases: past successes and future prospects, undated
65 42
Untitled ["There seems little reason to doubt that antibody in serum is an important mediator"], c.1950s
65 43
Hemagluttination with the virus of western equine encephalitis - with Sabin, 30 November 1951
65 44
Hemagglutinins of St. Louis and western equine viruses - isolation, properties, and use for diagnosis and epidemiologic survey, 5 May 1952
65 45
The Hemagglutination test for Japanese encephalitis, a diagnosis and survey tool, 1955
65 46
Untitled ["I'd like to start off by describing in some detail, of course I'll probably be offending some, viruses and some of the tests we use in"], 25 November 1958
65 47
Mycoplasma pneumoniae infections - prospects for live and inactivated vaccines, c.1963
65 48
Infections caused by mycoplasmas, 4 November 1965
65 49
Australia antigen and serum hepatitis, 1970
65 50
Untitled [at International Congress of Microbiology], August 1970
65 51
Parainfluenza virus epidemiology, 3 May 1974
65 52
Untitled ["For approximately the past five years the Laboratory of Infectious Diseases at the NIH in Bethesda has been involved in the study of acute infectious nonbacterial gastroenteritis."], September 1975
65 53
Untitled ["This morning I would like to discuss two areas of study in which we have been involved concerning human reovirus-like agent of infantile gastroenteritis.", 1976
65 54
Chicago talk, 1977
65 55
R. E. Dyer lecture, 30 May 1978
65 56
Medicine for Laymen series lecture, 4 December 1979
65 57
Smadel lecture at Infectious Diseases Society meeting, 26 September 1980
65 58
Saz Immunology Lecture, 9 October 1985
65 59
Successful strategy for selection and characterization of live poliomyelitis virus vaccine strains, 27 October 1986
66 1
Feldman Memorial Lecture, 17-18 March 1987
66 2
FAES lecture, 7 December 1988
66 3-4
Talamo lecture, 4 April 1990
66 5
Children's Hospital National Medical Center, 22 October 1990
66 6
Respiratory syncytial virus: thirty-five year status report on research achievements, opportunities and frustrations, 7 February 1991
66 7
Careers in virology: a good beginning is usually required for a good ending, 7 or 12 February 1991
66 8
Albert Sabin eulogy, 1993
66 9
Natural history of RSV, 1994
66 10-11
Sabin Lecture, Cold Spring Harbor, September 1995
66 12
Untitled ["sabin.doc"], 1997
66 13
Huebner Symposium lecture, 10 November 1999
66 14
Speech in honor of Brian Murphy, 2003
66 15
R. Walter Schlesinger, M.D. (1913-2003), 5 November 2003
66 16
Tribute to Albertk Kapikian, honored with Albert Sabin Foundation Gold Medal, 16 May 2005
 
Series 8: Videocassettes, 1985-1987 [series]:
67
Wallace P. Rowe Symposium [11 Umatic videocassettes], 12 February 1985
68
A Scientific Symposium in Honor of Albert B. Sabin's 80th Birthday [9 Umatic, 5 vhs videocassettes], 26 August 1986
68
Bldg10/ACRF [1 Umatic videocassette], 11 May 1987